Overview of Dr. Harms
Dr. Matthew Harms is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of California (San Francisco) School of Medicine and has been in practice 14 years. Dr. Harms accepts several types of health insurance, listed below. He is one of 484 doctors at New York-Presbyterian Hospital and one of 211 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. He has more than 80 publications and over 500 citings.
Office
710 West 168th Street
New York, NY 10032
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Clinical Neurophysiology, 2007 - 2008
- University of California (San Francisco)Internship, Internal Medicine, 2003 - 2004
- University of California San Francisco School of MedicineClass of 2003
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2015 - 2026
- NJ State Medical License 2022 - 2025
- MO State Medical License 2007 - 2016
- CA State Medical License 2005 - 2010
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
Publications & Presentations
PubMed
- 16 citationsDominant mutations in ITPR3 cause Charcot-Marie-Tooth disease.Julius Rönkkö, Svetlana M. Molchanova, Anya Revah-Politi, Elaine M. Pereira, Mari Auranen
Annals of Clinical and Translational Neurology. 2020-09-19 - 42 citationsMyopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformers.Kevin C. Stein, Rocio Bengoechea, Matthew B. Harms, Conrad C. Weihl, Heather L. True
The Journal of Biological Chemistry. 2014-07-25 - 446 citationsTargeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degenerationClotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, Shuying Sun, Patrick Liu
Proceedings of the National Academy of Sciences of the United States of America. 2013-11-19
Press Mentions
- Variety of Advocacy, Fundraising Events Mark ALS Awareness MonthMay 4th, 2021
- Lithium Boosts Muscle Strength in Mice with Rare Muscular DystrophyJune 3rd, 2019
- The New Study Brings Good News for the People with Limb-Girdle Muscular DystrophyApril 22nd, 2019
- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access Choice PPO
Anthem Blue Access PPO
BCBS Blue Card PPO
BCBS California PPO
BCBS Illinois PPO
Blue Shield California PPO
CIGNA HMO
CIGNA Open AccessCIGNA PPO
Great West PPO
Health Net California Large Group PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: